Literature DB >> 9509428

Doubling of serum creatinine: is it sensitive and relevant?

P Rossing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9509428     DOI： 10.1093/ndt/13.2.244

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine.

Authors:  Noriko Takeuchi; Emi Takenoshita; Fumino Kato; Tomoko Terajima; Makoto Ogawa; Satoshi Suzuki; Takayuki Fujii; Eriko Kobayashi; Tomoya Sakurada; Nobunori Satoh; Shiro Ueda
Journal:  Clin Exp Nephrol       Date:  2010-11-09       Impact factor: 2.801

2.  Sepsis-Associated Acute Kidney Disease and Long-term Kidney Outcomes.

Authors:  Alexander H Flannery; Xilong Li; Natalie L Delozier; Robert D Toto; Orson W Moe; Jerry Yee; Javier A Neyra
Journal:  Kidney Med       Date:  2021-04-16

3.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

4.  The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.

Authors:  Robert G Fassett; Madeleine J Ball; Iain K Robertson; Dominic P Geraghty; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-03-18       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.